Cytosorbents Change To Liabilities from 2010 to 2025

CTSO Stock  USD 1.06  0.01  0.93%   
Cytosorbents Crp Change To Liabilities yearly trend continues to be very stable with very little volatility. Change To Liabilities is likely to grow to about -3.5 M this year. During the period from 2010 to 2025, Cytosorbents Crp Change To Liabilities quarterly data regression pattern had sample variance of 4.1 T and median of  148,000. View All Fundamentals
 
Change To Liabilities  
First Reported
2009-12-31
Previous Quarter
629.9 K
Current Value
-338.8 K
Quarterly Volatility
737.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents Crp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 135 K or Selling General Administrative of 45.7 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.002 or PTB Ratio of 2.01. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.
  
Check out the analysis of Cytosorbents Crp Correlation against competitors.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

Latest Cytosorbents Crp's Change To Liabilities Growth Pattern

Below is the plot of the Change To Liabilities of Cytosorbents Crp over the last few years. It is Cytosorbents Crp's Change To Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.
Change To Liabilities10 Years Trend
Slightly volatile
   Change To Liabilities   
       Timeline  

Cytosorbents Change To Liabilities Regression Statistics

Arithmetic Mean(284,700)
Geometric Mean558,515
Coefficient Of Variation(711.61)
Mean Deviation1,580,623
Median148,000
Standard Deviation2,025,966
Sample Variance4.1T
Range6.2M
R-Value(0.53)
Mean Square Error3.2T
R-Squared0.28
Significance0.03
Slope(225,244)
Total Sum of Squares61.6T

Cytosorbents Change To Liabilities History

2025-3.5 M
2024-3.7 M
2022-3.2 M
20212.4 M
20201.1 M
20191.4 M
20181.7 M

About Cytosorbents Crp Financial Statements

Cytosorbents Crp investors utilize fundamental indicators, such as Change To Liabilities, to predict how Cytosorbents Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Liabilities-3.7 M-3.5 M
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out the analysis of Cytosorbents Crp Correlation against competitors.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.36)
Revenue Per Share
0.72
Quarterly Revenue Growth
0.066
Return On Assets
(0.28)
Return On Equity
(1.19)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.